Copertina

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autore principale:	M. V. Protsenko (Autore)
Natura:	Libro
Pubblicazione:	IRBIS LLC, 2015-03-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS
di: A. Yu. Kulikov, et al.
Pubblicazione: (2015)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS
di: A. Yu. Kulikov, et al.
Pubblicazione: (2015)

Epidemiological characterization of primary open-angle glaucoma
di: Leonor Rosario Díaz Alfonso, et al.
Pubblicazione: (2010)

Epidemiological characterization of primary open-angle glaucoma
di: Leonor Rosario Díaz Alfonso, et al.
Pubblicazione: (2010)

A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma
di: Sudeepthi Padala, et al.
Pubblicazione: (2020)

Clinical evaluation of the effectiveness of a new fixed combination antihypertensive drug based on brimonidine and brinzolamide in primary open-angle glaucoma
di: F. Bakhritdinova, et al.
Pubblicazione: (2024)

Evaluation of efficacy of dorsamed in combination with timolol 0.5% in the treatment of primary open-angle glaucoma
di: G.O. Kliuiev, et al.
Pubblicazione: (2016)

Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
di: Ting NSJ, et al.
Pubblicazione: (2014)

Results of phosphene electrostimulation treatment of patients with primary open-angle glaucoma
di: V. A. Putienko, et al.
Pubblicazione: (2016)

Genetic susceptibility to the development of primary open angle glaucoma
di: A.M. Sergienko, et al.
Pubblicazione: (2018)

Use of photomyostimulation method in treatment of patients with advanced primary open angle glaucoma
di: V.A. Putienko, et al.
Pubblicazione: (2017)

Speed of development and speed of progression of primary open-angle glaucoma
di: S.O. Rykov, et al.
Pubblicazione: (2018)

Non-compliance with Drug Therapy in Patients with Primary Open-angle Glaucoma
di: Ariana Fernández García, et al.
Pubblicazione: (2012)

The association between primary open-angle glaucoma and helicobacter pylori infection
di: Mohammad Mehdi Raji, et al.
Pubblicazione: (2021)

Primary open-angle glaucoma progression depending on clinical indices at presentation
di: S.Iu. Mogilevskyy, et al.
Pubblicazione: (2016)

Identification and validation of autophagy-related genes in primary open-angle glaucoma
di: Wanjing Xu, et al.
Pubblicazione: (2023)

Evaluation of Redox Profiles of the Serum and Aqueous Humor in Patients with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
di: Yuji Takayanagi, et al.
Pubblicazione: (2020)

Efficacy of phacoemulsification combined with goniosynechialysis for primary angle closure glaucoma
di: I. Ia. Novytskyy, et al.
Pubblicazione: (2020)

Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors
di: Supuran CT
Pubblicazione: (2020)

Agreement of Optic Nerve Head Evaluation of Primary Open-Angle Glaucoma Between General Ophthalmologists and Glaucoma Specialists
di: Zhu W, et al.
Pubblicazione: (2021)

Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye
di: Konstantin Tachkov, et al.
Pubblicazione: (2019)

Assessing factors of endothelial vascular dysfunction in patients with primary open-angle glaucoma
di: A. M. Dusmukhamedova, et al.
Pubblicazione: (2022)

Retinal ganglion cell-specific genetic regulation in primary open-angle glaucoma
di: Maciej Daniszewski, et al.
Pubblicazione: (2022)

Two-year results of treatment of open-angle glaucoma and concomitant cataract with combined phacoemulsification and Alcon EX-PRESS glaucoma filtration implant surgery
di: S. P. Medvedchuk, et al.
Pubblicazione: (2015)

Evaluation of corneal morphology among newly detected patients with primary open angle glaucoma
di: Nagalakshmi Narayana-Swamy, et al.
Pubblicazione: (2020)

Study of visual evoked potentials in clinical practice in the patients with primary open-angle glaucoma
di: L.M. Stotska, et al.
Pubblicazione: (2016)

Experimental substantiation of modified non-penetrating deep sclerectomy for primary open-angle glaucoma
di: E.A. Ivachev
Pubblicazione: (2017)

Mobility of oculomotor system and lability of visual analyzer in patients with primary open-angle glaucoma
di: V.A. Putienko, et al.
Pubblicazione: (2016)

Report on the clinical study of glautan and original travoptost in patients with primary open angle glaucoma
di: Soboleva IA
Pubblicazione: (2021)

An overview of carbohydrate-based carbonic anhydrase inhibitors
di: Doretta Cuffaro, et al.
Pubblicazione: (2020)

Efficacy assessment of treatment of patients with stage III primary open-angle glaucoma using a combined method (phosphene electrical stimulation and photomyostimulation)
di: V.A. Putienko, et al.
Pubblicazione: (2017)

Association of <it>IL1A </it>and <it>IL1B </it>loci with primary open angle glaucoma
di: Mukhopadhyay Indranil, et al.
Pubblicazione: (2010)

Assessing the impact of short-term intraocular pressure fluctuations on primary open-angle glaucoma progression
di: Nina Lutsenko, et al.
Pubblicazione: (2024)

Predicting the development and progression of primary open-angle glaucoma based on the determination of GST gene polymorphisms
di: S.O. Rykov, et al.
Pubblicazione: (2018)

Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
di: Claudiu T. Supuran
Pubblicazione: (2022)

Coumarin carbonic anhydrase inhibitors from natural sources
di: Claudiu T. Supuran
Pubblicazione: (2020)

Efficacy of Latanoks (latanaprost 0.005%) in patients with open-angle glaucoma
di: Shambra SV, et al.
Pubblicazione: (2015)

PREVENCION DE CEGUERA EN PACIENTES CON GLAUCOMA PRIMARIO DE ANGULO ABIERTO Blindness prevention in patients with primary open angle glaucoma
di: Eglis Esteban García Alcolea, et al.
Pubblicazione: (2009)

Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?
di: Claudiu T. Supuran
Pubblicazione: (2018)

Additive Intraocular Pressure Lowering Effects of Ripasudil in Patients with Primary Open Angle Glaucoma and Ocular Hypertension
di: Asma Jabeen, et al.
Pubblicazione: (2024)